ライフサイエンスコーパス: bioluminescence

1 nfish can see their own, otherwise rare, red bioluminescence).

2 ng the possible role of ferritin in the worm bioluminescence.

3 phase when using a caliper as compared with bioluminescence.

4 nes to coordinate group behaviors, including bioluminescence.

5 ic slice cultures was monitored as PER2::LUC bioluminescence.

6 ently available luciferases that exhibit NIR bioluminescence.

7 tly oxidizes to oxyluciferin, the emitter of bioluminescence.

8 er cells; tumor growth was measured based on bioluminescence.

9 from luciferase to GAF-FP, resulting in NIR bioluminescence.

10 associated with host colonization, including bioluminescence.

11 py, tumors regressed and possessed decreased bioluminescence.

12 ve microbial behavior, such as virulence and bioluminescence.

13 onding mutants of NanoLuc that enable bright bioluminescence.

14 to entrain the circadian rhythm in PER2::LUC bioluminescence.

15 he spectrum of both downwelling sunlight and bioluminescence.

16 reverse engineer promoter activity from the bioluminescence.

17 and the D-luciferin substrate had levels of bioluminescence 11-fold greater than colons of mice give

18 regulation implies an adaptive function for bioluminescence, a controversial question for more than

19 to the independent and repeated evolution of bioluminescence across the tree of life.

20 ma cells with aequorin reporter gene and the bioluminescence activities of stable biosensor were meas

21 em by oxidizers conventionally used to track bioluminescence activity.

22 ppression of tumor size, but the decrease of bioluminescence after CR-PIT was not observed consistent

23 luciferases promises to expand the power of bioluminescence and allow multiple events to be imaged i

24 re oxygen [8] and energy (NADH or NADPH) for bioluminescence and are reported to emit green light (la

25 tastatic spreading by three-dimensional (3D) bioluminescence and cross-validated it with standard bio

26 BKC showed no significant difference between bioluminescence and enumeration.

27 Optical bioluminescence and fluorescence imaging confirmed tumor

28 acy tests (PET) using bacterial replication, bioluminescence and fluorescence in a three-way study.

29 lization of the position the tumor with MRI, bioluminescence and fluorescence reflectance imaging, an

30 However, Malcosteus niger produces far-red bioluminescence and its longwave retinal sensitivity is

31 Our study demonstrates that dual noninvasive bioluminescence and NIR fluorescence imaging of cancer x

32 S/AinR pheromone-signaling system to control bioluminescence and other symbiotic colonization factors

33 umor response to oncolysis sequentially with bioluminescence and positron emission tomography (PET),

34 ctivity of exposed airway samples using both bioluminescence and standard colony-forming unit assays.

35 al (metastatic) growth were quantified using bioluminescence and were then used to generate a mathema

36 uch as those of radioluminescence (1-1.5 h), bioluminescence ( approximately 30 min) and low-excitati

37 hat energy-consuming processes (motility and bioluminescence) are downregulated, and microarray-based

38 stems our study emphasizes the importance of bioluminescence as a speciation driver.

39 cycles suggests a mechanical stimulation of bioluminescence, as organisms carried by currents collid

40 rcadian rhythms in C elegans recorded with a bioluminescence assay in vivo and demonstrate the main f

41 A bioluminescence assay was employed to study their inhibi

42 Here we report a novel bioluminescence assay, designated MPO activity on a poly

43 Using an ATP bioluminescence assay, we found that mechanical or cold

44 ymbionts, enhances their capacity to produce bioluminescence at night.

45 by a green LED emitting light similar to the bioluminescence, attract staphilinid rove beetles (coleo

46 Bioluminescence based on Saa3 promoter activity in Saa3-

47 ominent reporter protein for a wide range of bioluminescence-based detection applications.

48 Here, using a highly effective bioluminescence-based reporter system and other tools, w

49 Here, we have developed a new multicolored bioluminescence-based reporter system that can specifica

50 Bioluminescence-based screening of small molecule modula

51 can be visualized by bioluminescent imaging, bioluminescence being detected in the snout and lungs of

52 ul colonization of habitats ranging from the bioluminescence-biased but basically dark deep sea to cl

53 Bioluminescence (BL) is a spectacular phenomenon involvi

54 served as a marker of infection detected as bioluminescence (BLM) by in vivo and ex vivo imaging.

55 was quantified relative to a control using a bioluminescence camera system at day 7 after sonication.

56 Bioluminescence can be detected from the purified protei

57 occurs across diverse taxa, measurements of bioluminescence can be powerful to detect and quantify o

58 The luciferase-catalyzed bioluminescence can be quenched by peptide-conjugating A

59 50,000 observations are classified for their bioluminescence capability based on literature descripti

60 ed that 76% of the observed individuals have bioluminescence capability.

61 acterial infection imaging for fluorescence, bioluminescence, chemiluminescence and photoacoustic ima

62 sing standard microscopy techniques, such as bioluminescence, chemiluminescence or radioluminescence.

63 Good correlations between bioluminescence, colony-forming units (CFU) count and fl

64 Bioluminescence commonly influences pelagic trophic inte

65 s that reached a maximum of 74.8-fold higher bioluminescence compared with uninduced mice.

66 ent pelagic photon budget, which we term the bioluminescence compensation depth.

67 gy transfer and bimolecular fluorescence and bioluminescence complementation.

68 Interestingly, bioluminescence conferred a survival advantage to the ba

69 n level can be distinguished in tissue-level bioluminescence data without the need for single-cell me

70 nd cut off, which results in the recovery of bioluminescence due to the release of luciferase from Au

71 for precise timing and expression levels of bioluminescence during quorum sensing.

72 ence detection (including chemiluminescence, bioluminescence, electrogenerated chemiluminescence, and

73 show that 5-HT2AR interacts with SAP97 using bioluminescence energy transfer and that overexpression

74 Coincident at this depth was bioluminescence exceeding atmospheric light in the ambie

75 allows a direct comparison between in vitro bioluminescence experiments and in silico ordinary diffe

76 However, bioluminescence experiments track the mean output from t

77 Gene reporters for bioluminescence, fluorescence, radionuclide, and magneti

78 In vitro data along with optical bioluminescence/fluorescence imaging were used to valida

79 fold increase in pancreas-specific NF-kappaB bioluminescence following 12 h of caerulein compared wit

80 species or higher rates in lineages that use bioluminescence for defense, a function presumably not u

81 ibiotic treatment were assessed by recording bioluminescence for short-time periods and by recording

82 The transducer also controls bioluminescence from firefly luciferase by affecting sol

83 gle i.p. injections of g-E and g-EAR delayed bioluminescence from metastasizing ES-2-luc cells for 2

84 Here, however, we report that bioluminescence from the mycelium of Neonothopanus gardn

85 Finally, bioluminescence functions in communication, attracting p

86 mit light of longer wavelength than standard bioluminescence-generating proteins, greatly enhance sen

87 r (IHF) is a key coactivator of the luxCDABE bioluminescence genes that is required together with Lux

88 Bioluminescence has been widely used for important biose

89 Given these results, bioluminescence has to be considered an important ecolog

90 Discrete medullar lesions, confirmed by bioluminescence images, were efficiently imaged with [(8

91 e- and effector number-dependent increase in bioluminescence imaging (BLI) activity of the caspase-3

92 njected, and tumor growth was monitored with bioluminescence imaging (BLI) and magnetic resonance ima

93 wo iRFP chimeras enables combined multicolor bioluminescence imaging (BLI) and the respective multico

94 erefore, we investigated luciferase-mediated bioluminescence imaging (BLI) as a non-invasive techniqu

95 wo noninvasive imaging technologies, MRI and bioluminescence imaging (BLI), we can visualize both the

96 d area of murine heart and probed by MRI and bioluminescence imaging (BLI).

97 er system in cell culture and living mice by bioluminescence imaging (BLI).

98 ansduction of colorectal mucosa, as shown by bioluminescence imaging analysis.

99 prachiasmatic nucleus (SCN) firing rate with bioluminescence imaging and locomotor activity monitorin

100 construct, lesions can be identified through bioluminescence imaging and single-photon emission compu

101 tumor viability and volume were monitored by bioluminescence imaging and ultrasound imaging.

102 In this study, using real-time bioluminescence imaging and virological assays, as expec

103 ility and left ventricular function, whereas bioluminescence imaging assessed stem cell engraftment d

104 o perform, for the first time, P. falciparum bioluminescence imaging at single-cell level.

105 Bioluminescence imaging became a widely used technique f

106 Bioluminescence imaging demonstrated better survival whe

107 Bioluminescence imaging enables non-invasive tracking of

108 Here, we used noninvasive bioluminescence imaging in a mouse model to dissect rela

109 e as exemplary reagents for greatly improved bioluminescence imaging in FAAH-expressing tissues such

110 of alphaSYN was monitored noninvasively with bioluminescence imaging in the mouse striatum and substa

111 Bioluminescence imaging is a powerful approach for visua

112 Bioluminescence imaging of CTS transplanted onto hearts

113 Furthermore, noninvasive bioluminescence imaging of histone methylation sensors c

114 xytamoxifen, by employing FLuc-based optical bioluminescence imaging of living mice.

115 ocyclic drug efficacy using highly sensitive bioluminescence imaging of murine infections.

116 ifically designed to allow simultaneous live bioluminescence imaging of the mouse brain, allowing rea

117 the site of metastasis, correlating with the bioluminescence imaging of the tumor.

118 address this knowledge gap through real-time bioluminescence imaging of transgenic Nrf2-luciferase (N

119 Liver tissues were collected and analyzed by bioluminescence imaging or immunofluorescence.

120 In vivo bioluminescence imaging showed ECFC persisted for 14 day

121 Bioluminescence imaging showed limited engraftment on tr

122 Bioluminescence imaging showed stable engraftment with n

123 e model system in combination with real-time bioluminescence imaging to demonstrate the relative impo

124 efficiency, we used nonlinear ultrasound and bioluminescence imaging to optimize the acoustic pressur

125 vasive visualization of tumor vascularity by bioluminescence imaging was possible.

126 Whole-body bioluminescence imaging was used to record total fluxes

127 Whole-body bioluminescence imaging was used to study the effect of

128 SPECT imaging and bioluminescence imaging were performed daily up to 48 h

129 cific expression of luciferase and performed bioluminescence imaging with an FFA probe.

130 oped to monitor biofilm formation, utilizing bioluminescence imaging with equine P. aeruginosa isolat

131 Bioluminescence imaging with luciferase-luciferin pairs

132 Bioluminescence imaging with luciferase-luciferin pairs

133 luracil ((3)H-FEAU) cellular uptake, in vivo bioluminescence imaging, and 9-(4-(18)F-fluoro-3-hydroxy

134 ed carrying reporter genes for fluorescence, bioluminescence imaging, and human PET reporter genes.

135 eration in the major organs, two-dimensional bioluminescence imaging, and three-dimensional diffuse l

136 escence and cross-validated it with standard bioluminescence imaging, caliper measurement and necrops

137 Bioluminescence imaging, histological examination, and c

138 Tumor growth was monitored with bioluminescence imaging, showing that CAR T cell treatme

139 inant Gaussia luciferase (rGluc) protein and bioluminescence imaging.

140 rugs on p53 sumoylation in living mice using bioluminescence imaging.

141 Tumor growth was monitored using bioluminescence imaging.

142 vated downstream ER signaling as measured by bioluminescence imaging.

143 ibiting apoptosis, and this was confirmed by bioluminescence imaging.

144 All results were validated with bioluminescence imaging.

145 rferon alpha/beta receptor knockout mice via bioluminescence imaging.

146 nd tumors were imaged over time with PET and bioluminescence imaging.

147 of viral infection and immunity, noninvasive bioluminescence imaging.

148 ely probed using multiparametric deep-tissue bioluminescence imaging.

149 n pneumococcal load in the lungs via in vivo bioluminescence imaging.

150 liferation in hiPSC-CMs was quantified using bioluminescence imaging.

151 ompromised mice, and followed by noninvasive bioluminescence imaging.

152 effects of CR-PIT in vitro and in vivo using bioluminescence imaging.

153 s produced, which can be detected by in vivo bioluminescence imaging.

154 ing the engraftment ratio (ER) using in vivo bioluminescence imaging.

155 Metastasis was monitored by bioluminescence imaging.

156 Voltage-gated proton channels, HV1, trigger bioluminescence in dinoflagellates, enable calcification

157 d voltage-regulated H(+) channels activating bioluminescence in firefly and jellyfish.

158 Because bioluminescence in Motyxia has been experimentally demon

159 lso suggests that the evolutionary origin of bioluminescence in nonphotosynthetic dinoflagellates may

160 to cover the major existing applications for bioluminescence in the context of the diversity of lucif

161 We detected localised bioluminescence in the liver (APAP) and kidneys (cisplat

162 The discovery of bioluminescence in X. bistipita and its pivotal phylogen

163 on of the invertebrate Daphnia magna and the bioluminescence inhibition of the marine bacteria Vibrio

164 The bioluminescence intensity at 470 nm is observed, and inc

165 The bioluminescence intensity of this designed sensor is sig

166 ation of bioluminescent data is limited: the bioluminescence is different from gene expression becaus

167 ian control may optimize energy use for when bioluminescence is most visible, attracting insects that

168 capability of animals to emit light, called bioluminescence, is considered to be a major factor in e

169 ich converts the antibody-antigen binding to bioluminescence light.

170 This is in agreement with bioluminescence live imaging, confocal microscopy, and h

171 rol of several cellular processes, including bioluminescence (luciferase), fluorescence (enhanced gre

172 applications in cancer imaging (fluorescence/bioluminescence, magnetic resonance (MR), positron emiss

173 The results provide insight into a novel bioluminescence mechanism in nature.

174 However there is a lack of a validated bioluminescence method.

175 oped a highly translational and quantitative bioluminescence microscopy method to measure single cell

176 uciferase reporter transgene for noninvasive bioluminescence monitoring of CREB activity.

177 pH dependent fluorescence spectra and emits bioluminescence of different colors with different engin

178 The bioluminescence of dinoflagellates, alveolate protists t

179 The bioluminescence of P. leiognathi is generated within a h

180 Bioluminescence optical imaging analysis was employed to

181 0.65 mm(3) +/- 0.15, P < .0001) and relative bioluminescence optical imaging photon signal (0.57 x 10

182 0.65 mm(3) +/- 0.15, P < .0001) and relative bioluminescence optical imaging photon signal (0.57 x 10

183 We demonstrate that bioluminescence originated in the group's most recent co

184 lation coefficients between CFU and relative bioluminescence; P. aeruginosa ATCC9027 tatH5-pMElux is

185 lia site, were used to characterize rhythmic bioluminescence patterns in June 2013, in response to wa

186 tinuously, implying a metabolic function for bioluminescence, perhaps as a byproduct of oxidative met

187 Bioluminescence potential of the community increased wit

188 This mechanism may be a common feature of bioluminescence processes in which light is produced by

189 ted-state formation in chemiluminescence and bioluminescence processes.

190 eness of the method by modeling experimental bioluminescence profiles of light-sensitive fibroblasts,

191 that for subcutaneously implanted cells, NIR bioluminescence provided a 10-fold increase in sensitivi

192 laces the BRD9 bromodomain from chromatin in bioluminescence proximity assays without affecting the B

193 ated ALL, successful MV treatment (judged by bioluminescence quantification and survival) was complet

194 red with the broadband time-resolved firefly bioluminescence recorded in vivo.

195 ow that the damping rate of population-level bioluminescence recordings can serve as an accurate meas

196 pared with control (100% vs 0%), and in vivo bioluminescence recordings showed a similar rapid decrea

197 In long-term bioluminescence recordings, GABAA receptor blockade desy

198 This emission is the most red-shifted bioluminescence reported without using a resonance energ

199 maximal information coefficient statistic to bioluminescence reporter data from individual neurons wh

200 Serial in vivo bioluminescence reporter gene imaging in mice with tMCAO

201 Novel manganese-enhanced MRI and bioluminescence reporter gene imaging were applied to fo

202 each variant were tested individually using bioluminescence reporters and biofilm growth assays, and

203 Red-shifted bioluminescence reporters are desirable for biological i

204 ular kinetics were imaged with Fluc and Rluc bioluminescence reporters plus two 18F-labeled PET repor

205 tively, oscillate in a circadian manner with bioluminescence reporters.

206 o and in vivo sensitivity over commonly used bioluminescence reporters.

207 But bioluminescence requires the interaction of a luciferase

208 Multiplexed bioluminescence resonance energy transfer (BRET) assays

209 ouple to dopamine D1R receptors by real-time bioluminescence resonance energy transfer (BRET) assays.

210 Due to an intramolecular bioluminescence resonance energy transfer (BRET) between

211 ditional signaling investigation approaches, bioluminescence resonance energy transfer (BRET) biosens

212 Using bioluminescence resonance energy transfer (BRET) in live

213 ular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) in live

214 Bioluminescence resonance energy transfer (BRET) is a we

215 Bioluminescence resonance energy transfer (BRET) is ofte

216 ecular fluorescein arsenical hairpin (FlAsH) bioluminescence resonance energy transfer (BRET) reporte

217 salmeterol-mediated desensitization through bioluminescence resonance energy transfer (BRET) studies

218 sent a new sensor platform (LUMABS) based on bioluminescence resonance energy transfer (BRET) that al

219 We utilized bioluminescence resonance energy transfer (BRET) to dete

220 e describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reve

221 Here we use bioluminescence resonance energy transfer (BRET) to show

222 We have used bioluminescence resonance energy transfer (BRET) to stud

223 robing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we det

224 e of them for their functional efficacies in bioluminescence resonance energy transfer (BRET)-based a

225 Here we developed an intramolecular bioluminescence resonance energy transfer (BRET)-based b

226 operties and high affinity, as determined by bioluminescence resonance energy transfer (BRET)-based s

227 (++) sensor that is ratiometric by virtue of bioluminescence resonance energy transfer (BRET).

228 eceptors in the intact cell as determined by bioluminescence resonance energy transfer (BRET).

229 lphas, and beta-arrestin1 were studied using bioluminescence resonance energy transfer 2 (BRET(2)) in

230 Our in vivo bioluminescence resonance energy transfer analyses in Ar

231 odimers, as demonstrated by experiments with bioluminescence resonance energy transfer and bimolecula

232 e now use competitive inhibition of receptor bioluminescence resonance energy transfer and bimolecula

233 Bioluminescence resonance energy transfer and co-immunop

234 By using bioluminescence resonance energy transfer and superresol

235 Using a bioluminescence resonance energy transfer approach to mo

236 Using cross-linking and bioluminescence resonance energy transfer approaches, we

237 Bioluminescence resonance energy transfer assays for Gi

238 d in OXE-R-overexpressing HEK293 cells using bioluminescence resonance energy transfer assays.

239 T was detected by co-immunoprecipitation and bioluminescence resonance energy transfer assays.

240 -fused Galpha constructs that can be used in bioluminescence resonance energy transfer assays.

241 vator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between Ggamma

242 ous ligands with G protein subtypes by using bioluminescence resonance energy transfer biosensors mon

243 Bioluminescence resonance energy transfer experiments pr

244 ing alanine-scanning mutagenesis, in cellulo bioluminescence resonance energy transfer experiments, a

245 of the Go protein by GluK1 was validated in bioluminescence resonance energy transfer experiments, w

246 Bioluminescence resonance energy transfer measurements i

247 arrestin2, Rab5, Rab7, and Rab11 proteins in bioluminescence resonance energy transfer measurements t

248 APJ mutants in TMD1 and TMD2 also decreased bioluminescence resonance energy transfer of APJ dimer.

249 The bioluminescence resonance energy transfer signal exhibit

250 Co-immunoprecipitation and bioluminescence resonance energy transfer studies confir

251 Bioluminescence resonance energy transfer studies showed

252 n of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique sugg

253 Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and

254 r fractionation, co-immunoprecipitation, and bioluminescence resonance energy transfer that combined

255 The intramolecular bioluminescence resonance energy transfer that occurs be

256 Here we used bioluminescence resonance energy transfer to monitor inh

257 Bioluminescence resonance energy transfer was employed t

258 A BRET (bioluminescence resonance energy transfer) assay reveale

259 A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacol

260 By combining bioluminescence resonance energy transfer, bimolecular c

261 We used in vitro bioluminescence resonance energy transfer, ex vivo analy

262 Using bioluminescence resonance energy transfer, immunofluores

263 ocal microscopy or with a recently developed bioluminescence resonance energy transfer-based approach

264 Using a bioluminescence resonance energy transfer-based assay (C

265 Using a bioluminescence resonance energy transfer-based assay (C

266 ith measuring changes in the GAP activity by bioluminescence resonance energy transfer-based assay in

267 We also developed a bioluminescence resonance energy transfer-based assay to

268 a large panel of G protein subtypes using a bioluminescence resonance energy transfer-based assay wi

269 Importantly, by using a robust bioluminescence resonance energy transfer-based assay, w

270 Here, we describe a unique bioluminescence resonance energy transfer-based AtAtg8 s

271 Using bioluminescence resonance energy transfer-based biosenso

272 eceptor signaling to NF-kappaB, we developed bioluminescence resonance energy transfer-based interact

273 to form a functional carrier as assessed by bioluminescence resonance energy transfer; 3) in MPC1 de

274 We adapted this pair to develop a bioluminescence resonance-energy-based Antares reporter

275 The normal circadian bioluminescence rhythm and the expected changes in Lucif

276 mine induced phase-advances of the PER2::LUC bioluminescence rhythm during the subjective day and pha

277 responsible for entrainment of the PER2::LUC bioluminescence rhythm in mouse RPE-choroid.

278 Furthermore, after excystment, the bioluminescence rhythm initiates at a time corresponding

279 Bioluminescence rhythms from cellular reporters have bec

280 circadian and rapidly induced PER2-dependent bioluminescence rhythms in previously arrhythmic Cry1/2-

281 as more severe, as indicated by increases in bioluminescence, S. aureus CFU in tissue, and death with

282 Moreover, the SiPM-based bioluminescence sensing system shows a similar analytica

283 A miniaturised bioluminescence sensing system, which would allow sensit

284 ltrasonographic imaging were used to observe bioluminescence signal and changes in tumor size among t

285 bserved a significant increase (~15 fold) in bioluminescence signal compared to control after 8-h inc

286 ificant (p < 0.05) 20.5 h periodicity in the bioluminescence signal, corresponding to inertial fluctu

287 Bioluminescence signals of tumors treated with 0.3 mg of

288 vein inoculation, most luciferase-generated bioluminescence signals were detected in the mouse abdom

289 g, wave guiding and lensing, camouflage, and bioluminescence, that are responsible for the unique opt

290 Bioluminescence, the creation and emission of light by o

291 oxycycline was precisely evaluated utilizing bioluminescence to measure ATP efflux and fluorescence t

292 erases and luciferins, further expanding the bioluminescence toolkit.

293 ession was measured in EPEC-infected mice by bioluminescence using an in vivo imaging system (IVIS).

294 ectrometry imaging, fluorescence tomography, bioluminescence, variations of OCT, and optoacoustic ima

295 Tumor burden, as determined by bioluminescence, was decreased in (+)-JQ1 treated mice c

296 gical iron and catalytic energy for the worm bioluminescence when coupled to a reduction process with

297 luciferin analogues that elicit red-shifted bioluminescence with firefly luciferase (Fluc).

298 iRFPs, the chimeric luciferases exhibit NIR bioluminescence with maxima at 670 nm and 720 nm, respec

299 off of the promoter, or where an increase in bioluminescence would be better interpreted as a longer

300 We show examples where a decrease in bioluminescence would be better interpreted as a switchi